BUZZ-Australia's Emyria rises on potential listing in Frankfurt exchange
Reuters
Feb 12
BUZZ-Australia's Emyria rises on potential listing in Frankfurt exchange
** Shares of Australia's Emyria EMD.AX rise as much as 5.5% to A$0.058, their highest level since February 5
** The early-stage drug developer says EMD securities can now be traded in Europe on Frankfurt Open Market
** "European investor outreach is a logical extension of our strategy to improve accessibility for institutional and specialist healthcare investors," says Greg Hutchinson, executive chairman of Emyria
** Stock down 1.7% YTD, including session's moves
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.